Dorothy H. Bray
Nessuna posizione attualmente
Profilo
Dorothy H.
Bray was the founder who founded Immunoclin Corp.
in 2013, where she held the titles of President, Chief Executive Officer & Director until 2017.
She also held former positions as President & Chief Executive Officer of Pharma Investing News, Inc. from 2013 to 2014, Chairman, President & Chief Executive Officer of Cannabis Science, Inc. in 2014, and Director of Endocan Corp.
from 2013 to 2016.
Additionally, she was a Global Director-HIV Research at GlaxoSmithKline LLC.
Dr. Bray holds a doctorate from the University of London and an undergraduate degree from Uniwersytet Jagiellonski, which she received in 1978.
Precedenti posizioni note di Dorothy H. Bray
Società | Posizione | Fine |
---|---|---|
IMMUNOCLIN CORP | Fondatore | 01/10/2017 |
ENDOCAN | Presidente | - |
CANNABIS SCIENCE, INC. | Amministratore Delegato | 05/11/2014 |
Pharma Investing News, Inc.
Pharma Investing News, Inc. Internet Software/ServicesTechnology Services Pharma Investing News, Inc. is a niche Internet-based company that provides Internet advertising solutions to the pharmaceutical, biotechnology and the healthcare industry. The company develops manages and executes marketing campaigns to an international audience, utilizing both existing website and other online media channels. It campaigns help its clients promote their goods and services directly to their target investment community, and are intended to assist them in achieving maximum exposure while increasing investor awareness. The company was founded on February 8, 2011 and is headquartered in Beverly Hills, CA. | Amministratore Delegato | 10/02/2014 |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
Formazione di Dorothy H. Bray
Uniwersytet Jagiellonski | Undergraduate Degree |
University of London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ENDOCAN | Electronic Technology |
Aziende private | 4 |
---|---|
Cannabis Science, Inc.
Cannabis Science, Inc. Pharmaceuticals: OtherHealth Technology Cannabis Science, Inc. develops cannabis pharmaceutical products. It works on phytocannabinoid science targeting critical illnesses and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. The company was founded by Raymond C. Dabney on February 29, 1996 and is headquartered in Irvine, CA. | Health Technology |
Pharma Investing News, Inc.
Pharma Investing News, Inc. Internet Software/ServicesTechnology Services Pharma Investing News, Inc. is a niche Internet-based company that provides Internet advertising solutions to the pharmaceutical, biotechnology and the healthcare industry. The company develops manages and executes marketing campaigns to an international audience, utilizing both existing website and other online media channels. It campaigns help its clients promote their goods and services directly to their target investment community, and are intended to assist them in achieving maximum exposure while increasing investor awareness. The company was founded on February 8, 2011 and is headquartered in Beverly Hills, CA. | Technology Services |
Immunoclin Corp.
Immunoclin Corp. BiotechnologyHealth Technology Immunoclin Corp. operates as an healthcare company. Its products include Multi-Variant Atherosclerosis Risk Assessment, Genetic Alzheimer's Risk Discovery, PRIMALEUKIN, and interleukin-22. The company was founded on February 8, 2011 and is headquartered in Washington, DC. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
- Borsa valori
- Insiders
- Dorothy H. Bray